Literature DB >> 2131822

Investigation of the adducts formed by reaction of malondialdehyde with adenosine.

K Stone1, M B Ksebati, L J Marnett.   

Abstract

Malondialdehyde (MDA) forms oligomeric adducts with DNA bases. It has been proposed that the 2:1 MDA-guanosine (M2G) and 3:1 MDA-adenosine (M3A) adducts result from sequential addition of MDA molecules to the nucleoside base. Reaction of 1:1 MDA-guanosine (M1G) and 1:1 MDA-adenosine (M1A) adducts with MDA does not produce the multimeric adducts. This suggests they arise by reaction of the nucleoside bases with oligomers of MDA. If so, the proposed structure for M3A is inconsistent with the addition of an MDA trimer to adenosine. Therefore, we investigated the structure of this molecule. Two-dimensional double quantum filtered COSY and hetero-COSY NMR experiments were performed, and a series of insensitive nuclei assignment by polarization transfer (INAPT) NMR spectra were also recorded. The results of these experiments revealed the presence of a propano group and two alpha,beta-unsaturated aldehydes. The UV spectrum of M3A displayed a maximum at 326 nm, similar to that of N6-[3-oxo-1(E)-propenyl]adenosine (M1A). The adducts were reduced with sodium borohydride for comparison of the UV and NMR spectra. On the basis of our results, a new structure for M3A is proposed which is tentatively named 6(5*,7*-diformyl-2*H-3*,6*-dihydro-2*,6*-methano-1*,3*-oxazocin -3*-yl)-9-beta-D-ribofuranosylpurine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2131822     DOI: 10.1021/tx00013a006

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

1.  Chronic unpredictable stress (CUS) enhances the carcinogenic potential of 7,12-dimethylbenz(a)anthracene (DMBA) and accelerates the onset of tumor development in Swiss albino mice.

Authors:  Nida Suhail; Nayeem Bilal; Shirin Hasan; Ausaf Ahmad; Ghulam Md Ashraf; Naheed Banu
Journal:  Cell Stress Chaperones       Date:  2015-08-14       Impact factor: 3.667

2.  Site-specific synthesis of oligonucleotides containing malondialdehyde adducts of deoxyguanosine and deoxyadenosine via a postsynthetic modification strategy.

Authors:  Hao Wang; Ivan D Kozekov; Albena Kozekova; Pamela J Tamura; Lawrence J Marnett; Thomas M Harris; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

3.  Replication, repair, and translesion polymerase bypass of N⁶-oxopropenyl-2'-deoxyadenosine.

Authors:  Leena Maddukuri; Sarah C Shuck; Robert L Eoff; Linlin Zhao; Carmelo J Rizzo; F Peter Guengerich; Lawrence J Marnett
Journal:  Biochemistry       Date:  2013-11-15       Impact factor: 3.162

Review 4.  Generation of mutagens during arachidonic acid metabolism.

Authors:  L J Marnett
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

5.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

6.  "One-pot" syntheses of malondialdehyde adducts of nucleosides.

Authors:  Jozsef Szekely; Hao Wang; Katherine M Peplowski; Charles G Knutson; Lawrence J Marnett; Carmelo J Rizzo
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-02       Impact factor: 1.381

7.  Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment.

Authors:  Lawrence J Marnett
Journal:  J Org Chem       Date:  2012-04-30       Impact factor: 4.354

8.  Drug-induced oxidative stress and toxicity.

Authors:  Damian G Deavall; Elizabeth A Martin; Judith M Horner; Ruth Roberts
Journal:  J Toxicol       Date:  2012-08-05

9.  Translesion DNA synthesis by human DNA polymerase eta on templates containing a pyrimidopurinone deoxyguanosine adduct, 3-(2'-deoxy-beta-d-erythro-pentofuranosyl)pyrimido-[1,2-a]purin-10(3H)-one.

Authors:  Jennifer B Stafford; Robert L Eoff; Albena Kozekova; Carmelo J Rizzo; F Peter Guengerich; Lawrence J Marnett
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.